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OF the many factors involved in the response of a malignant tumour to a
chemotherapeutic agent, the ability of the agent administered to reach the
cancer cell is of primary importance.
The vasculature of malignant tumours has been frequently investigated by
means of angiographic studies and by observations on the distribution of blood-
borne dyes (Goldmann, 1911; Sampson, 1912; Lewis, 1927; Saito, 1937;
Shinkawa, 1939; Ide, Baker and Warren, 1939; Algire and Chalkley, 1945;
Algire, 1947; Braithwaite, 1958; Waters and Green, 1959; Smart, McKinna and
Griffiths, 1963). Other studies, not specific to vascular supply, were concerned
with the distribution ofdyes in the interstitial compartment. Most notable in this
respect was the work of Goldacre and Sylven (1962) who used the dye Lissamine
Green V. They concluded that there were large areas in many tumours not
readily reached by blood-borne substances. The implication of these findings in
relation to the penetration of cytotoxic drugs in tumours has been emphasised
(Newton, 1965). However, Lissamine Green V is a large complex molecule which
differs markedly from many chemotherapeutic agents in common use (Fig. 1).
The purpose of this investigation, therefore, was to ascertain whether the
tumour distribution of the dye Lissamine Green V corresponded with that of a
radio-actively labelled chemotherapeutic agent.
MATERIALS AND METHOD
The distribution of 35S-labelled sulphur mustard (di 2-chloroethyl 35S sulphide)
and thymidine-6-T(n) was examined in 30 Walker 256 carcino-sarcomata grown
in Wistar rats (Chester Beatty strain). Tumours 9-12 days old were selected
since, at this time, varying degrees of necrosis had occurred and a comparison in
distribution of labelled agent in these largely necrotic areas and the remainder of
the tumours could be made. The largest diameter of these tumours varied from
3 cm to 4-4 cm., the average tumour diameter being 3-5 cm. The labelled agents
were injected intravenously in a dose of 1 mCi and the animals were killed at
intervals of 15 minutes to 3 hours. 35S-labelled sulphur mustard was used in
18 animals and thymidine-6-T(n) in 12 animals. An intravenous injection of
Lissamine Green V was made (1 ml. of a 2 % solution) in the same animal so that
the distribution of the labelled agents could be contrasted with that of the dye.
Following the death ofthe animal, the tumours were bisected and one halfwas
set aside for autoradiographic examination. Small portions of tissue (average
* Based on a paper read to the Surgical Research Society at Aberdeen in July 1967.
t Present adress: Royal Victoria Hospital, Shelley Road, Bournemouth.D. C. ROWE-JONES
20 mg.) were removed across the diameter of the remaining half of the tumour,
9 to 10 samples being taken from each tumour. These pieces of tissue were
dissolved in 1 ml. of tetra ethyl ammonium hydroxide, being left in sealed tubes,
in a water bath at 600 C. for 12 hours. The concentration of labelled agent
present was then determined by a liquid scintillation counter. The distance that
the samples lay from the tumour edge was noted, as was their relation to the
distribution ofthe dye.
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FIG. 1.-(a) Lissamine Green V (b) Sulphur mustard (c) Mustine hydrochloride
(d) 5-Fluorouracil.
Paraffin was removed from the unstained sections and autoradiographs were
prepared by covering them with Kodak AR-10 stripping film and at varying
intervals of exposure from 3 to 7 weeks, the emulsions were developed and the
tissues stained with Nuclear Fast Red and Alcian Blue.
RESULTS
The results obtained from the scintillation counter are shown in Tables I-IV.
It was apparent that the distribution of the Lissamine Green V corresponded
with the histological appearance ofthe tumour in that, in areas stained green, the
tumour appeared to be viable whereas in those not reached by the dye, there was
evidence ofnecrosis (Fig. 2). However, although the concentration of35S mustard
and SH thymidine was higher in the green-stained area ofthe tumour, penetration
still occurred in the non-stained regions.
Further, it was noticed that the maximum concentration of isotope labelled
agent following injection was achieved more rapidly in the green-stained, than in
156PENETRATION OF CYTOTOXINS INTO TUMOURS
TABLE L.-35S Sulphur Mustard-Scintillation Count8/Minute/Mg.
ofTissue in Viable Zone
At tumour edge
Time Tumour . A_
interval number A B
(min.)
15 . 1 . 933
2 . 874 922
3 . 942 -
30 . 4 . 952
5 . 978 942
6 994 820
45 . 7 . 1025 1080
8 . 998* -
9 . 1036* 1116*
80 . 10 1119 974
I1 1092 892
12 . 1139* 991*
120 . 13 1172 1264
14 . 1179t 1100t
15 . 998t
180 . 16 . 1064t 947t
17 . 1184t 1260t
18 . 1103t
At junctional zone mm. from tumour edge
4 5 6 7 5 3
892
818
901
934
1001
977*
1007*
1102
1111
1131*
1239
940t
925
841
936
1067*
918
1008*
958
1284t
1166t
Standard 10 m*Ci. = 13,771 counts. Background = 192 counts.
* Standard 10 m,uCi. = 13,952 counts. Background = 271 counts.
t Standard 10 m,Ci. = 13,860 counts. Background = 185 counts.
TABLE II.-35S Sulphur MUstard-Scintillation Count8/Minute/Mg.
ofTissue in Necrotic Zone
Time
interval Tumour
(min.) number
15 . 1
2
3
30 . 4
5
6
45 . 7
8
9
80 . 10
11
12
120 . 13
14
15
180 . 16
17
18
mm. from junction with viable tumour
2 3 5 6 11 15 16 9 5 3 2
.198 - 141 78 108 -
164 - 116 64 169 207 -
.188 92 84 123 177
- - 184 90 303
.- - 171 138.- - 347
- 263 - - 110 - 192 -
.408 - 314 194 -.-.387
- 298* - 181* 153* 243* 341* - 369*
- 364* - 188* 173* - 191* 376* -
.680 - - 280 641
.672 254 - 583 -
.- - 536* - 268* 123* 298* 613*
703 - 375 612
- 695t - - 420t - 627t -
678t - - 369t - 539t -
698t - - 576t 408t 595t 730t
.713t 573t - 480t - 531t -
.696t - - 599t 638t 688t
Standard 10 m,uCi. = 13,771 counts. Background = 192 counts.
* Standard 10 m,uCi. = 13,952 counts. Background = 271 counts.
t Standard 10 m,uCi. = 13,860 counts. Background = 185 counts.
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TABLE III.-Thymidine-6-T(n)-Scintillktion Counts/Minute/Mg.
ofTissue in Viable Zone
Time
interval Tumour
(min.) number
30 1
2
3
60 . 4
5
6
100 . 7
8
130 . 9
10
180 . 11
12
At tumour edge
A B
937
928
891
942
976
953
1179t
981t
1172*
1191*
1094*
1133*
921
802
936
958
957
926
995t
1085t
1322*
1200*
1163*
1109*
At junctional zone mm. from tumour edge ~~~~~~~~A
4
1196*
1244*
5 7
941
912
836
932
962t -
1022t
1088*
1107* -
Standard 10 mpCi. = 13,920 counts. Background = 283 counts.
* Standard 10 m*sCi. = 14,435 counts. Background = 179 counts.
t Standard 10 m,Ci. = 13,541 counts. Background = 208 counts.
5
899
961
944
947t
1016t
1231*
1039*
1115*
3
875
912
960
1111*
TABLE IV.-Thymidine-6-T(n)-Scintillation Counts/Minute/Mg.
ofTissue in Necrotic Zone
Time
interval Tumour
(min.) number
30 . 1
2
3
60 . 4
5
6
100 . 7
8
130 . 9
10
180 . 11
12
mm. from junction with viable tumour
A
2 3 5 9 10 11 15 10 5
415
397
571
396
683t
731t
876*
861*
407
483
343
339
593t
621t
792*
250
227
296
473t
678*
184
102
281
469t
606*
384t 399t
326
411
389
784*
. 933* - 902* 762* 619*
928* - - 830* - 841* 778* 888*
3 2
- 324
- 351
406
- 525
406 -
633t
- 713t
- 915*
829* -
- 956*
912*
Standard 10 m,uCi. = 13,920 counts. Background = 283 counts.
* Standard 10 m,zCi. = 14,435 counts. Background = 179 counts.
t Standard 10 m,uCi. = 13,541 counts. Background = 208 counts.
the non-stained areas. With both labelled agents, 90 % ofmaximum concentration
was achieved in 1 hour in the stained area of the tumour, whereas in the non-
stained portion the concentration ofagent continued to rise as the time the tumour
was exposed to the agent was increased (Fig. 3). Consequently, as the time
interval between injection ofthe agent and the death ofthe animal increased, the
difference in concentration of agent in stained and unstained areas became less
(Fig. 3, 4).
A fall in concentration of agent was observed as the distance between the area
sampled and the edge of the tumour increased. This fall in concentration was
maximum across the first few millimetres ofunstained tumour (Fig. 4). Agradient
across the stained portion of tumour only occurred when the time of tumour
exposure to agent was short, i.e. less than 15 minutes.
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FIG. 3. The difference in concentration of 35S mustard in viable and necrotic areas of tumour.
The readings in the viable region were taken from the tumour edge and in the necrotic zone
from a point 1 cm. inside the junction with viable tumour. The concentration of labelled
agent increases as the time interval between its injection and the death ofthe animal becomes
greater.
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FiG. 4.-The fall in concentration of isotope labelled agent is maximum across the first 2 mm.
of unstained tumour. 100% concentration represents the highest level ofagent found in the
stained peripheral portion of the tumour.
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Samples ofskin and muscle contained isotope-labelled agent in a concentration
of 20 % less than that obtained at the periphery of the stained tumour areas.
Whether or not these findings support the concept of selective tumour uptake
has not been established, since samples from other tissues and organs such as
liver and kidney, which might have shown a higher level ofagent, were not studied.
In support of observations recorded previously, namely, the presence of
isotope-labelled agent in unstained areas of tumour, uptake of 3H thymidine was
demonstrated in these areas by means ofan autoradiographic technique. Although
the unstained regions were largely necrotic, islands of cells with a histologically
viable appearance occurred in them and further, these cells were seen to take up
3H thymidine (Fig. 5-8). This established the viability of these cells since
thymidine is only taken up by cells activelv synthesising deoxyribonucleic acid
(DNA) (Reichard and Estborn, 1951; Friedkin et al., 1956; Hughes et al., 1958;
Kisieleski et al., 1961).
DISCUSSION
In contrast to the distribution of the dye, labelled cytotoxic agent was found
in all areas of the tumour examined and it would appear that the distribution of
any agent administered will depend, to some extent, upon such physical character-
istics as molecular weight, structure and electrical charge. The superior penetra-
tion of 35S mustard as compared with Lissamine Green V may be related to their
molecular weights of 170 and 576 respectively. Of course some low molecular
weight substances become rapidly bound to protein and might then behave more
like Lissamine Green V.
In the unstained, largely necrotic regions of the tumour, drug concentration
begins to reach levels comparable with those reached in the stained viable areas
only when exposure to the drug has continued for a long time, e.g. 25% of the
concentration present in the viable region is achieved only after 80 minutes'
exposure (Fig. 4). When this time of exposure is short, i.e. less than 15 minutes,
penetration of agent corresponds closely with that of the dye. Maximum con-
centration of agent is achieved more rapidly in the viable areas of tumour, e.g.
90 % of maximum concentration being achieved in 1 hour (cf. Rubini et al., 1960).
These findings support the work of Shapiro and Landing (1948) who found the
distribution of flourescein in sarcoma 180 in mice to be determined by the length
of time after injection and the presence or absence of necrosis in the tumour.
Moving from the periphery towards the centre ofthe tumour, the concentration
of agent becomes less and a rapid fall occurs across the first few millimetres of the
unstained necrotic area. It must be remembered that the physical conditions
EXPLANATION OF PLATES
FIG. 2. A 12 day old Walker 256 tumour (3-5 cm. diameter) following the intravenous
injection of Lissamine Green V. The unstained central area of tumour is largely necrotic.
FIG. 5.-Autoradiograph using thymidine, from the centre of tumour. Small island of viable
cells labelled with thymidine within predominantly necrotic tissue. x 225.
FJG. 6. Enlarged portion of Fig. 5. This area of tumour is unstained by the dye although
some cells take up thymidine as shown by the black granules. x 500.
FIG. 7. Autoradiograph taken from the periphery of the same tumour as shown in Fig. 5.
This is a fully viable area which is readily penetrated by Lissamine Green V injected
intravenously. x 225.
FIG. 8.-Higher magnification ofFig. 7 with a large number ofheavily labelled cells. x 500.
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inside the necrotic centre ofthis transplanted tumour which becomes vascularised
with some difficulty, may not be the same as occur in the necrotic areas of spon-
taneous tumours. If the same situation does exist however, then the penetration
of cytotoxic agent will be limited in a large tumour, especially when areas of
necrosis are present. That penetration of cytotoxic drugs into these regions is
important is shown by the ability of cells present in these areas to take up thy-
midine and therefore to synthesise DNA. When treatment of human tumours is
broken off because of general toxicity, some of the surviving tumour cells may
divide and provide a sufficient " background growth " ultimately to produce
therapeutic failure, without the need to invoke any mechanism of resistance
(Klein, 1961).
These results indicate that, in the Walker 265 tumour, penetration ofcytotoxic
agent is a function oftumour mass, the presence or absence ofnecrosis, the time of
exposure to the drug and the physical characteristics of the agent used. Initial
observations, which have since been made in eight different human tumours,
appear to confirm the importance of these factors in determining the penetration
of cytotoxic drugs and the accessibility ofmany cancer cells to cytotoxic drugs in
large malignant tumours especially those with considerable areas of necrosis, will
be limited. This will apply particularly to many alkylating agents with a short
biological half-life, chosen because of their ability to produce less side effects and
which, therefore, come into contact with the tumour for only a short time while in
an active form. It is possible also that an antimetabolite, having a specific
affinity for a particular molecule present in the viable part of a tumour but not in
a largely necrotic area (e.g. methotrexate and dihydrofolate reductase), might be
diverted from the latter by mass-action. However, if the molecular structure
remains simple, the use of an antimetabolite which persists for a long time and
would ultimately reach the necrotic part of the tumour may be indicated in
preference to a rapidly inactivated alkylating agent in the treatment of a large
tumour mass.
The results obtained in this study support the statement by Larionov (1959)
based on clinical material that " the degree of anti tumour effect is inversely
proportional to the mass of tumour tissue ".
SUMMARY
1. The distribution of 35S mustard and 3H thymidine was examined in 30
Walker 256 carcino-sarcomata.
2. Comparisons between the penetration ofthese agents and the dye Lissamine
Green V were made.
3. Penetration of agent was found to be a function of tumour mass, the
presence or absence ofnecrosis, the time of exposure to the drug and the physical
characteristics of the agent used.
4. The possible relevance ofthese findings to the use of cytotoxic agents in the
treatment of malignant human tumours was discussed.
This work was carried out at the Royal Marsden and Westminster Hospitals,
London. I am indebted to Mr. J. D. Griffiths who first stimulated my interest in
this subject and to Professor H. Ellis and Dr. L.Cobb for advice andMiss Rosemary
Ellis for technical assistance. Part of this work was supported by a grant from
the Board of Governors' Discretionary Fund, Westminster Hospital.
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